Burlington Stores (BURL) 10-Q26 Nov 242025 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information	9 Months Ended
Document and Entity Information	Nov. 02, 2024 shares
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Nov. 02, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Trading Symbol	BURL
Entity Registrant Name	BURLINGTON STORES, INC.
Entity Central Index Key	0001579298
Current Fiscal Year End Date	--02-01
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding	63,481,004
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-36107
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	80-0895227
Entity Address, Address Line One	2006 Route 130 North
Entity Address, City or Town	Burlington
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	08016
City Area Code	609
Local Phone Number	387-7800
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common stock
Security Exchange Name	NYSE
Document Quarterly Report	true
Document Transition Report	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
REVENUES:
Net sales	$ 2,526,174	$ 2,284,673	$ 7,344,685	$ 6,587,912
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Other revenue	$ 4,522	$ 4,673	$ 13,081	$ 13,197
Total revenue	2,530,696	2,289,346	7,357,766	6,601,109
COSTS AND EXPENSES:
Cost of sales	1,418,143	1,297,805	4,156,989	3,795,661
Selling, general and administrative expenses	893,092	826,822	2,582,299	2,357,736
Costs related to debt amendments	4,553		4,553	97
Depreciation and amortization	87,470	76,087	256,094	219,749
Impairment charges - long-lived assets	3,044	814	11,254	6,367
Other income - net	(12,825)	(12,384)	(33,179)	(27,549)
Loss on extinguishment of debt	1,412	13,630	1,412	38,274
Interest expense	17,769	19,680	51,000	58,570
Total costs and expenses	2,412,658	2,222,454	7,030,422	6,448,905
Income before income tax expense	118,038	66,892	327,344	152,204
Income tax expense	27,441	18,341	84,473	40,013
Net income	$ 90,597	$ 48,551	$ 242,871	$ 112,191
Net income per common stock - basic	$ 1.43	$ 0.75	$ 3.81	$ 1.73
Net income per common stock - diluted	$ 1.4	$ 0.75	$ 3.77	$ 1.73
Weighted average number of common stock - basic	63,563	64,707	63,723	64,852
Weighted average number of common stock - diluted	64,619	64,802	64,395	65,024

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 90,597	$ 48,551	$ 242,871	$ 112,191
Interest rate derivative contracts:
Net unrealized gain arising during the period	15,895	7,618	14,593	17,029
Net reclassification into earnings during the period	(3,476)	(1,386)	(10,166)	(3,391)
Other comprehensive income, net of tax	12,419	6,232	4,427	13,638
Total comprehensive income	$ 103,016	$ 54,783	$ 247,298	$ 125,829

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Current assets:
Cash and cash equivalents	$ 857,800	$ 925,359	$ 615,863
Accounts receivable—net	102,872	74,361	91,579
Merchandise inventories	1,440,695	1,087,841	1,329,129
Assets held for disposal	32,444	23,299	23,299
Prepaid and other current assets	256,609	216,164	154,962
Total current assets	2,690,420	2,327,024	2,214,832
Property and equipment—net	2,109,025	1,880,325	1,767,626
Operating lease assets	3,264,632	3,132,768	3,130,574
Tradenames	238,000	238,000	238,000
Goodwill	47,064	47,064	47,064
Deferred tax assets	2,131	2,436	2,870
Other assets	91,588	79,223	92,734
Total assets	8,442,860	7,706,840	7,493,700
Current liabilities:
Accounts payable	1,101,920	956,350	939,658
Current operating lease liabilities	401,840	411,395	412,303
Other current liabilities	626,860	647,338	588,645
Current maturities of long term debt	170,823	13,703	13,970
Total current liabilities	2,301,443	2,028,786	1,954,576
Long term debt	1,542,712	1,394,942	1,397,618
Long term operating lease liabilities	3,124,116	2,984,794	2,982,549
Other liabilities	74,091	73,793	70,572
Deferred tax liabilities	254,011	227,593	237,909
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.0001 par value: authorized: 50,000,000 shares; no shares issued and outstanding
Common stock, $0.0001 par value: Authorized: 500,000,000 shares Issued: 82,781,089 shares, 82,399,577 shares and 82,354,291 shares, respectively Outstanding: 63,481,004 shares, 63,964,371 shares and 64,525,262 shares, respectively	8	8	8
Additional paid-in-capital	2,216,224	2,118,356	2,086,798
Accumulated earnings	1,226,935	984,064	756,606
Accumulated other comprehensive income	37,960	33,533	42,386
Treasury stock, at cost	(2,334,640)	(2,139,029)	(2,035,322)
Total stockholders' equity	1,146,487	996,932	850,476
Total liabilities and stockholders' equity	$ 8,442,860	$ 7,706,840	$ 7,493,700

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Statement of Financial Position [Abstract]
Preferred Stock, Par Value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred Stock, Authorized	50,000,000	50,000,000	50,000,000
Preferred Stock, Issued	0	0	0
Preferred Stock, Outstanding	0	0	0
Common Stock, Par Value	$ 0.0001	$ 0.0001	$ 0.0001
Common Stock, Authorized	500,000,000	500,000,000	500,000,000
Common Stock, Shares Issued	82,781,089	82,399,577	82,354,291
Common Stock, Shares Outstanding	63,481,004	63,964,371	64,525,262

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		9 Months Ended
		Nov. 02, 2024	Oct. 28, 2023
OPERATING ACTIVITIES
Net income		$ 242,871	$ 112,191
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization		256,094	219,749
Impairment charges—long-lived assets		11,254	6,367
Amortization of deferred financing costs		2,285	2,380
Accretion of long term debt instruments		732	706
Deferred income taxes		25,094	27,254
Loss on extinguishment of debt		1,412	38,274
Non-cash stock compensation expense	[1]	69,296	57,792
Non-cash lease expense		(4,891)	(4,068)
Cash received from landlord allowances		9,253	7,739
Changes in assets and liabilities:
Accounts receivable		(29,120)	(20,611)
Merchandise inventories		(352,854)	(147,146)
Prepaid and other current assets		(40,445)	(23,271)
Accounts payable		163,738	(20,249)
Other current liabilities		(22,564)	17,197
Other long term assets and long term liabilities		376	1,113
Other operating activities		(12,319)	(5,221)
Net cash provided by operating activities		320,212	270,196
INVESTING ACTIVITIES
Cash paid for property and equipment		(527,065)	(304,442)
Lease acquisition costs		(9,306)	(20,481)
Net proceeds from sale of property and equipment and assets held for sale		485	13,639
Net cash used in investing activities		(535,886)	(311,284)
FINANCING ACTIVITIES
Proceeds from long term debt- 2027 Convertible Notes			297,069
Principal payment on long term debt- 2025 Convertible Notes			(386,519)
Purchase of treasury shares		(194,200)	(140,482)
Proceeds from stock option exercises		28,573	13,380
Other financing activities		7,371	1,509
Net cash provided by (used in) financing activities		148,115	(222,254)
Decrease in cash and cash equivalents		(67,559)	(263,342)
Cash and cash equivalents at beginning of period		925,359	879,205
Cash and cash equivalents at end of period		857,800	615,863
Supplemental disclosure of cash flow information:
Interest paid		61,939	62,083
Income tax payments - net		137,484	70,232
Non-cash investing and financing activities:
Finance lease modification		(1,523)
Accrued purchases of property and equipment		93,266	98,642
Term Loan Facility
FINANCING ACTIVITIES
Proceeds from long term debt-Term Loan Facility		605,843
Principal payments on long term debt-Term Loan Facility		$ (299,472)	$ (7,211)

[1] The amounts presented in the table above exclude taxes. For the three and nine month periods ended November 2, 2024 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 4.4 million and $ 12.3 million, respectively. For the three and nine month periods ended October 28, 2023 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 4.1 million and $ 10.9 million, respectively .

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Nov. 02, 2024	Aug. 03, 2024	May 04, 2024	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Nov. 02, 2024	Oct. 28, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 90,597	$ 73,760	$ 78,514	$ 48,551	$ 30,892	$ 32,748	$ 242,871	$ 112,191

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Nov. 02, 2024
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	During the three month period ended November 2, 2024 , no director or officer of the Company adopted , modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Modified	false
Non-Rule 10b5-1 Arrangement Modified	false

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Nov. 02, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	1. Summary of Significant Accounting Policies Basis of Presentation As of November 2, 2024, Burlington Stores, Inc., a Delaware corporation (collectively with its subsidiaries, the Company), through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 1,103 retail stores. These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2024 (Fiscal 2023 10-K). The balance sheet at February 3, 2024 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2023 10-K. Because the Company’s business is seasonal in nature, the operating results for the three and nine month periods ended November 2, 2024 are not necessarily indicative of results for the fiscal year. Accounting policies followed by the Company are described in Note 1, “Summary of Significant Accounting Policies,” included in Part II, Item 8 of the Fiscal 2023 10-K. Fiscal Year The Company defines its fiscal year as the 52 or 53-week period ending on the Saturday closest to January 31. Fiscal 2024 is defined as the 52-week year ending February 1, 2025, and Fiscal 2023 is defined as the 53-week year ended February 3, 2024. The first, second, and third quarters of Fiscal 2024 and Fiscal 2023 each consist of 13 weeks. Recently Adopted Accounting Standards There were no new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements and notes thereto during the three and nine month periods ended November 2, 2024. In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" (ASU 2023-07) to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The standard is effective for annual reporting periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. The Company is currently evaluating the impact of ASU 2023-07 on its disclosures in the consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topics 740): Improvements to Income Tax Disclosures" (ASU 2023-09) to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for annual reporting periods beginning after December 15, 2024, with early adoption permitted and can be applied on either a prospective or retroactive basis. The Company is currently evaluating the impact of ASU 2023-09 on its disclosures in the consolidated financial statements.

Stockholders_ Equity

Stockholders’ Equity	9 Months Ended
Stockholders’ Equity	Nov. 02, 2024
Stockholders' Equity Note [Abstract]
Stockholders’ Equity	2. Stockholders’ Equity Activity for the three and nine month periods ended November 2, 2024 and October 28, 2023 in the Company’s stockholders’ equity is summarized below: (in thousands, except share data) Common Stock Additional Accumulated Accumulated Treasury Stock Shares Amount Capital Earnings Income Shares Amount Total Balance at February 3, 2024 82,399,577 $ 8 $ 2,118,356 $ 984,064 $ 33,533 ( 18,435,206 ) $ ( 2,139,029 ) $ 996,932 Net income — — — 78,514 — — — 78,514 Stock options exercised 55,688 — 8,472 — — — — 8,472 Shares used for tax withholding — — — — — ( 63,407 ) ( 12,222 ) ( 12,222 ) Shares purchased as part of publicly announced program, inclusive of $ 0.4 million related to excise tax — — — — — ( 312,238 ) ( 63,769 ) ( 63,769 ) Vesting of restricted shares 181,607 — — — — — — — Stock based compensation — — 19,107 — — — — 19,107 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 2.8 million — — — — 7,735 — — 7,735 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 1.2 million — — — — ( 3,343 ) — — ( 3,343 ) Balance at May 4, 2024 82,636,872 8 2,145,935 1,062,578 37,925 ( 18,810,851 ) ( 2,215,020 ) 1,031,426 Net income — — — 73,760 — — — 73,760 Stock options exercised 89,961 — 15,393 — — — — 15,393 Shares used for tax withholding — — — — — ( 3,790 ) ( 916 ) ( 916 ) Shares purchased as part of publicly announced program, inclusive of $ 0.5 million related to excise tax — — — — — ( 269,508 ) ( 61,721 ) ( 61,721 ) Vesting of restricted shares 19,674 — — — — — — — Stock based compensation — — 24,779 — — — — 24,779 Unrealized losses on interest rate derivative contracts, net of related taxes of $ 3.3 million — — — — ( 9,037 ) — — ( 9,037 ) Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 1.2 million — — — — ( 3,347 ) — — ( 3,347 ) Balance at August 3, 2024 82,746,507 8 2,186,107 1,136,338 25,541 ( 19,084,149 ) ( 2,277,657 ) 1,070,337 Net income — — — 90,597 — — — 90,597 Stock options exercised 26,519 — 4,707 — — — — 4,707 Shares used for tax withholding — — — — — ( 2,564 ) ( 601 ) ( 601 ) Shares purchased as part of publicly announced program, inclusive of $ 0.5 million related to excise tax — — — — — ( 213,372 ) ( 56,382 ) ( 56,382 ) Vesting of restricted shares 8,063 — — — — — — — Stock based compensation — — 25,410 — — — — 25,410 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 5.8 million — — — — 15,895 — — 15,895 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 1.3 million — — — — ( 3,476 ) — — ( 3,476 ) Balance at November 2, 2024 82,781,089 $ 8 $ 2,216,224 $ 1,226,935 $ 37,960 ( 19,300,085 ) $ ( 2,334,640 ) $ 1,146,487 (in thousands, except share data) Common Stock Additional Accumulated Accumulated Treasury Stock Shares Amount Capital Earnings Income Shares Amount Total Balance at January 28, 2023 82,037,994 $ 8 $ 2,015,625 $ 644,415 $ 28,748 ( 17,018,281 ) $ ( 1,893,891 ) $ 794,905 Net income — — — 32,748 — — — 32,748 Stock options exercised 90,971 — 10,764 — — — — 10,764 Shares used for tax withholding — — — — — ( 9,457 ) ( 1,962 ) ( 1,962 ) Shares purchased as part of publicly announced program, inclusive of $ 0.4 million related to excise tax — — — — — ( 245,414 ) ( 51,823 ) ( 51,823 ) Vesting of restricted shares 28,536 — — — — — — — Stock based compensation — — 16,722 — — — — 16,722 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 0.3 million — — — — 947 — — 947 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 0.3 million — — — — ( 827 ) — — ( 827 ) Balance at April 29, 2023 82,157,501 8 2,043,111 677,163 28,868 ( 17,273,152 ) ( 1,947,676 ) 801,474 Net income — — — 30,892 — — — 30,892 Stock options exercised 15,236 — 1,512 — — — — 1,512 Shares used for tax withholding — — — — — ( 48,938 ) ( 8,626 ) ( 8,626 ) Shares purchased as part of publicly announced program, inclusive of $ 0.1 million related to excise tax — — — — — ( 154,358 ) ( 26,104 ) ( 26,104 ) Vesting of restricted shares 153,739 — — — — — — — Stock based compensation — — 19,425 — — — — 19,425 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 3.1 million — — — — 8,465 — — 8,465 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 0.4 million — — — — ( 1,179 ) — — ( 1,179 ) Balance at July 29, 2023 82,326,476 8 2,064,048 708,055 36,154 ( 17,476,448 ) ( 1,982,406 ) 825,859 Net income — — — 48,551 — — — 48,551 Stock options exercised 8,101 — 1,105 — — — — 1,105 Shares used for tax withholding — — — — — ( 3,633 ) ( 537 ) ( 537 ) Shares purchased as part of publicly announced program, inclusive of $ 0.5 million related to excise tax — — — — — ( 348,948 ) ( 52,379 ) ( 52,379 ) Vesting of restricted shares 19,714 — — — — — — — Stock based compensation — — 21,645 — — — — 21,645 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 2.8 million — — — — 7,618 — — 7,618 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 0.5 million — — — — ( 1,386 ) — — ( 1,386 ) Balance at October 28, 2023 82,354,291 $ 8 $ 2,086,798 $ 756,606 $ 42,386 ( 17,829,029 ) $ ( 2,035,322 ) $ 850,476

Lease Commitments

Lease Commitments	9 Months Ended
Lease Commitments	Nov. 02, 2024
Leases [Abstract]
Lease Commitments	3. Lease Commitments The Company’s leases primarily consist of stores, distribution facilities and office space under operating and finance leases that will expire principally during the next 30 years. The leases typically include renewal options at five-year intervals and escalation clauses. Lease renewals are only included in the lease liability to the extent that they are reasonably assured of being exercised. The Company’s leases typically provide for contingent rentals based on a percentage of gross sales. Contingent rentals are not included in the lease liability, and they are recognized as variable lease cost when incurred. The following is a schedule of the Company’s future lease payments: (in thousands) Fiscal Year Operating Finance 2024 (remainder) $ 100,447 $ 869 2025 665,226 3,526 2026 625,286 3,640 2027 583,996 3,640 2028 535,944 3,447 Thereafter 1,954,979 20,787 Total future minimum lease payments 4,465,878 35,909 Amount representing interest ( 939,922 ) ( 10,404 ) Total lease liabilities 3,525,956 25,505 Less: current portion of lease liabilities ( 401,840 ) ( 2,168 ) Total long term lease liabilities $ 3,124,116 $ 23,337 Weighted average discount rate 6.0 % 5.5 % Weighted average remaining lease term (years) 7.8 12.2 The above schedule excludes approximately $ 525.1 million for 49 stores and one distribution center that the Company has committed to open or relocate but has not yet taken possession of the space. The discount rates used in valuing the Company’s leases are not readily determinable, and are based on the Company’s incremental borrowing rate on a fully collateralized basis. The Company has entered into a lease agreement for a new distribution center in Ellabell, GA, which is expected to commence in Spring 2025. The Company does not have control of the asset during construction, but it is involved in the design and construction of the related asset. Additionally, the lease agreement has a purchase option, which can be exercised beginning after the earlier of (a) substantial completion of construction or (b) the date the Company commences business operations in the premises. The following is a schedule of net lease costs for the periods indicated: (in thousands) Three Months Ended Nine Months Ended November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Finance lease cost: Amortization of finance lease asset (a) $ 566 $ 877 $ 2,007 $ 2,630 Interest on lease liabilities (b) 351 454 1,096 1,425 Operating lease cost (c) 158,211 147,270 466,239 427,072 Variable lease cost (c) 63,652 58,915 186,204 168,864 Total lease cost 222,780 207,516 655,546 599,991 Impairment (gain) on sale and leaseback transaction (d) — — 8,210 ( 1,958 ) Less all rental income (e) ( 1,261 ) ( 1,383 ) ( 3,974 ) ( 4,224 ) Total net rent expense (f) $ 221,519 $ 206,133 $ 659,782 $ 593,809 (a) Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income. (b) Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income. (c) Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income. (d) Impairment included in the line item "Impairment charges - long-lived assets" and gain included in line item “Other income - net” in the Company’s Condensed Consolidated Statements of Income. (e) Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income. (f) Excludes an immaterial amount of short-term lease cost. Supplemental cash flow disclosures related to leases are as follows: (in thousands) Nine Months Ended November 2, 2024 October 28, 2023 Cash paid for amounts included in the measurement of lease liabilities: Cash payments arising from operating lease liabilities (a) $ 471,192 $ 431,200 Cash payments for the principal portion of finance lease liabilities (b) $ 2,041 $ 2,975 Cash payments for the interest portion of finance lease liabilities (a) $ 1,096 $ 1,425 Supplemental non-cash information: Operating lease liabilities arising from obtaining right-of-use assets $ 531,539 $ 494,327 (a) Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. (b) Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.

Long Term Debt

Long Term Debt	9 Months Ended
Long Term Debt	Nov. 02, 2024
Debt Disclosure [Abstract]
Long Term Debt	4. Long Term Debt Long term debt consists of: (in thousands) November 2, February 3, October 28, 2024 2024 2023 Senior secured term loan facility, adjusted SOFR (with a floor of 0.00 %) plus 1.75 %, matures on September 24, 2031 $ 1,241,737 $ 933,355 $ 935,507 Convertible senior notes, 2.25 %, mature on April 15, 2025 156,155 156,155 156,155 Convertible senior notes, 1.25 %, mature on December 15, 2027 297,069 297,069 297,069 ABL senior secured revolving facility, SOFR plus spread based on average outstanding balance, matures on December 22, 2026 — — — Finance lease obligations 25,505 29,069 30,471 Unamortized deferred financing costs ( 6,931 ) ( 7,003 ) ( 7,614 ) Total debt 1,713,535 1,408,645 1,411,588 Less: current maturities ( 170,823 ) ( 13,703 ) ( 13,970 ) Long term debt, net of current maturities $ 1,542,712 $ 1,394,942 $ 1,397,618 Term Loan Facility BCFWC and certain of its subsidiaries and holding companies are party to a Credit Agreement (as amended, supplemented and otherwise modified, the Term Loan Facility) that provides for term loans in an aggregate principal amount as of November 2, 2024 of $ 1,250 million maturing on September 24, 2031 . On September 24, 2024, the Company entered into an amendment to the Term Loan Facility dated as of February 24, 2011 (the "Amendment"), which among other things, (i) refinanced the outstanding $ 933 million principal amount of Term B-6 Loans with Term B-7 Loans in an aggregate principal amount of $ 1,250 million, which includes incremental term loans in an aggregate principal amount of $ 317 million, (ii) extended the maturity date from June 24, 2028 to September 24, 2031 , and (iii) reduced the interest rate margins applicable to the Company’s term loan facility from 1.00 % to 0.75 %, in the case of prime rate loans, and from 2.00 % to 1.75 %, in the case of SOFR loans, with a 0.00 % SOFR floor, and removed the SOFR adjustment. The Term B-7 Loans were issued with an original issue discount of 99.5 . The Term Loan Facility is collateralized by a first lien on BCFWC’s and each guarantor’s equity interests, equipment, intellectual property, and certain favorable leases and real estate, and certain related assets and proceeds thereof (subject to certain exceptions), and a second lien on BCFWC’s and each guarantor’s other assets and proceeds thereof (subject to certain exceptions). At November 2, 2024 and October 28, 2023 , the interest rate related to the Term Loan Facility was 6.4 % and 7.4 %, respectively. 2025 Convertible Notes On April 16, 2020, the Company issued its 2.25 % Convertible Senior Notes due 2025 (2025 Convertible Notes). The 2025 Convertible Notes are general unsecured obligations of the Company. The 2025 Convertible Notes bear interest at a rate of 2.25 % per year, payable semi-annually in cash, in arrears, on April 15 and October 15 of each year. The 2025 Convertible Notes will mature on April 15, 2025 , unless earlier converted, redeemed or repurchased. During the first quarter of Fiscal 2023, the Company entered into separate, privately negotiated exchange agreements with certain holders of the 2025 Convertible Notes. Under the terms of the exchange agreements, the holders exchanged $ 110.3 million in aggregate principal amount of 2025 Convertible Notes held by them for $ 133.3 million in cash. These exchanges resulted in aggregate pre-tax debt extinguishment charges of $ 24.6 million. Prior to the close of business on the business day immediately preceding January 15, 2025, the 2025 Convertible Notes will be convertible at the option of the holders only upon the occurrence of certain events and during certain periods. Thereafter, the 2025 Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The 2025 Convertible Notes have an initial conversion rate of 4.5418 shares per $ 1,000 principal amount of 2025 Convertible Notes (equivalent to an initial conversion price of approximately $ 220.18 per share of the Company’s common stock), subject to adjustment if certain events occur. The initial conversion price represents a conversion premium of approximately 32.50 % over $ 166.17 per share, the last reported sale price of the Company’s common stock on April 13, 2020 (the pricing date of the offering) on the New York Stock Exchange. During the first quarter of Fiscal 2021, the Company made an irrevocable settlement election for any conversions of the 2025 Convertible Notes. Upon conversion, the Company will pay cash for the principal amount. For any excess above principal, the Company will deliver shares of its common stock. The Company was not permitted to redeem the 2025 Convertible Notes prior to April 15, 2023. From and after April 15, 2023, the Company is able to redeem for cash all or any portion of the 2025 Convertible Notes, at its option, if the last reported sale price of the Company’s common stock is equal to or greater than 130 % of the conversion price for a specified period of time, at a redemption price equal to 100 % of the principal aggregate amount of the 2025 Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. Holders of the 2025 Convertible Notes may require the Company to repurchase their 2025 Convertible Notes upon the occurrence of certain events that constitute a fundamental change under the indenture governing the 2025 Convertible Notes at a purchase price equal to 100 % of the principal amount thereof, plus accrued and unpaid interest to, but excluding, the date of repurchase. In connection with certain corporate events or if the Company issues a notice of redemption, it will, under certain circumstances, increase the conversion rate for holders who elect to convert their 2025 Convertible Notes in connection with such corporate event or during the relevant redemption period for such 2025 Convertible Notes. The effective interest rate is 2.8 %. 2027 Convertible Notes On September 12, 2023, the Company closed the issuance of approximately $ 297.1 million aggregate principal amount of its 1.25 % Convertible Senior Notes due 2027 (2027 Convertible Notes) pursuant to separate, privately negotiated exchange and subscription agreements with a limited number of holders of its 2025 Convertible Notes and certain investors, in each case pursuant to exemptions from registration under the Securities Act of 1933. The Company exchanged approximately $ 241.2 million in aggregate principal amount of the 2025 Convertible Notes for approximately $ 255.0 million in aggregate principal amount of the 2027 Convertible Notes. This exchange resulted in aggregate pre-tax debt extinguishment charges of $ 13.6 million. The Company also issued approximately $ 42.1 million in aggregate principal amount of 2027 Convertible Notes in a private placement to certain investors. An aggregate of up to 1,422,568 shares of common stock may be issued upon conversion of the 2027 Convertible Notes, which number is subject to adjustment up to an aggregate of 1,911,372 shares following certain corporate events that occur prior to the maturity date or if the Company issues a notice of redemption, and which is also subject to certain anti-dilution adjustments. The 2027 Convertible Notes will bear interest at a rate of 1.25 % per year, payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2023. The 2027 Convertible Notes will mature on December 15, 2027 , unless earlier converted, redeemed or repurchased. Prior to the close of business on the business day immediately preceding September 15, 2027, the 2027 Convertible Notes will be convertible at the option of the holders only upon the occurrence of certain events and during certain periods. Thereafter, the 2027 Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The 2027 Convertible Notes have an initial conversion rate of 4.8560 shares per $ 1,000 principal amount of 2027 Convertible Notes (equivalent to an initial conversion price of approximately $ 205.93 per share of the Company’s common stock), subject to adjustment if certain events occur. The initial conversion price represents a conversion premium of approximately 32.50 % over $ 155.42 per share, the last reported sale price of the Company’s common stock on September 7, 2023 on The New York Stock Exchange. Upon conversion, the Company will pay cash up to the aggregate principal amount of 2027 Convertible Notes being converted, and pay (and deliver, if applicable) cash, shares of the Company’s common stock or a combination thereof, at its election, in respect of the remainder (if any) of the Company’s conversion obligation in excess of such aggregate principal amount. The Company will not be able to redeem the 2027 Convertible Notes prior to December 20, 2025. On or after December 20, 2025 and prior to the 21st scheduled trading day immediately preceding December 15, 2027, the Company will be able to redeem for cash all or any portion of the 2027 Convertible Notes, at its option, if the last reported sale price of the Company’s common stock is equal to or greater than 130 % of the conversion price for a specified period of time, at a redemption price equal to 100 % of the aggregate principal amount of the 2027 Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. If the Company undergoes a fundamental change, subject to certain conditions, holders of the 2027 Convertible Notes may require the Company to repurchase for cash all or any portion of their 2027 New Convertible Notes. The fundamental change repurchase price will be 100 % of the aggregate principal amount of the 2027 Convertible Notes to be repurchased plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The effective interest rate is 1.7 %. ABL Line of Credit BCFWC and certain of its subsidiaries and holding companies are party to a Second Amended and Restated Credit Agreement (as amended, supplemented and otherwise modified, the ABL Line of Credit) that provides for $ 900.0 million of revolving commitments (subject to a borrowing base limitation) maturing on December 22, 2026 , and, subject to the satisfaction of certain conditions, BCFWC can increase the aggregate amount of commitments up to $ 1,200 million. The interest rate margin applicable under the ABL Line of Credit is 1.125 % to 1.375 % in the case of a daily SOFR rate or a term SOFR rate (in each case, plus a credit spread adjustment of 0.10 %), and 0.125 % to 0.375 % in the case of a prime rate, depending on the average daily availability of the lesser of (a) the total commitments or (b) the borrowing base. The ABL Line of Credit is collateralized by a first priority lien on BCFWC’s and each guarantor's inventory, receivables, bank accounts, and certain related assets and proceeds thereof (subject to certain exceptions), and a second priority lien on BCFWC’s and each guarantor's other assets and proceeds thereof (other than real estate and subject to certain exceptions). On June 26, 2023, BCFWC entered into a Fifth Amendment to the Second Amended and Restated Credit Agreement, which increased the sublimit for letters of credit thereunder from $ 150 million to $ 250 million. The letter of credit sublimit was automatically reduced to $ 225 million on July 1, 2024, and $ 212.5 million on October 1, 2024, and will be automatically reduced to $ 200 million on January 1, 2025. At November 2, 2024 , the Company had $ 847.5 million available under the ABL Line of Credit. There were no borrowings under the ABL Line of Credit during the three and nine month periods ended November 2, 2024. At October 28, 2023 , the Company had $ 824.0 million available under the ABL Line of Credit. There were no borrowings under the ABL Line of Credit during the three and nine month periods ended October 28, 2023 .

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	9 Months Ended
Derivative Instruments and Hedging Activities	Nov. 02, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	5. Derivative Instruments and Hedging Activities The Company accounts for derivatives and hedging activities in accordance with ASC 815, “Derivatives and Hedging” (ASC 815). As required by ASC 815, the Company records all derivatives on the balance sheet at fair value and adjusts to market on a quarterly basis. In addition, to comply with the provisions of ASC 820, “Fair Value Measurements” (ASC 820), credit valuation adjustments, which consider the impact of any credit enhancements to the contracts, are incorporated in the fair values to account for potential nonperformance risk. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered any applicable credit enhancements such as collateral postings, thresholds, mutual puts, and guarantees. In accordance with ASC 820, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio. There is no impact of netting, because the Company has only one derivative. The Company classifies its derivative valuations in Level 2 of the fair value hierarchy. On June 24, 2021, the Company entered into an interest rate swap, which hedged $ 450 million of variable rate exposure on the Term Loan Facility at a blended rate of 2.19 %, and was designated as a cash flow hedge. The Company subsequently amended its interest rate swap to be based on SOFR rather than LIBOR, which resulted in an updated swap rate of 2.16 %. On September 27, 2024, the Company terminated the previous $ 450 million interest rate swap, and entered into a new interest rate swap in the notional amount of $ 500 million with a blended interest rate of 2.83 %. On this same date, the Company also entered into a new interest rate swap for $ 300 million with an interest rate of 3.37 %. These interest rate swap agreements are designated as cash flow hedges. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. As of November 2, 2024, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk: Interest Rate Derivative Number of Notional Aggregate Principal Amount Interest Swap Rate Maturity Date Interest rate swap contract Two $ 800.0 million 2.83 % - 3.37 % September 24, 2031 Tabular Disclosure The table below presents the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets: (in thousands) Fair Values of Derivative Instruments November 2, 2024 February 3, 2024 October 28, 2023 Derivatives Designated as Hedging Instruments Balance Fair Balance Fair Balance Fair Interest rate swap contracts Other assets $ 38,143 Other assets $ 29,075 Other assets $ 43,031 The following table presents the unrealized gains and losses deferred to accumulated other comprehensive income resulting from the Company’s derivative financial instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Interest Rate Derivatives: November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Unrealized gains, before taxes $ 21,696 $ 10,416 $ 19,931 $ 23,269 Income tax benefit ( 5,801 ) ( 2,798 ) ( 5,338 ) ( 6,240 ) Unrealized gains, net of taxes $ 15,895 $ 7,618 $ 14,593 $ 17,029 The following table presents information about the reclassification of gains and losses from accumulated other comprehensive income into earnings related to the Company’s derivative instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Component of Earnings: November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Interest benefit $ ( 4,745 ) $ ( 1,892 ) $ ( 13,876 ) $ ( 4,631 ) Income tax expense 1,269 506 3,710 1,240 Net reclassification into earnings $ ( 3,476 ) $ ( 1,386 ) $ ( 10,166 ) $ ( 3,391 ) The Company estimates that approximately $ 14.5 million will be reclassified from accumulated other comprehensive income as a reduction to interest expense during the next twelve months.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Nov. 02, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	6. Fair Value Measurements The Company accounts for fair value measurements in accordance with ASC 820, which defines fair value, establishes a framework for measurement and expands disclosure about fair value measurements. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price), and classifies the inputs used to measure fair value into the following hierarchy: Level 1: Quoted prices for identical assets or liabilities in active markets. Level 2: Quoted market prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. Level 3: Pricing inputs that are unobservable for the assets and liabilities and include situations where there is little, if any, market activity for the assets and liabilities. The inputs into the determination of fair value require significant management judgment or estimation. The carrying amounts of cash equivalents, accounts receivable and accounts payable approximate fair value due to the short-term nature of these instruments. Refer to Note 5, “Derivative Instruments and Hedging Activities,” for further discussion regarding the fair value of the Company’s interest rate swap contract. Financial Assets The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of November 2, 2024, February 3, 2024 and October 28, 2023 are summarized below: (in thousands) Fair Value Measurements at November 2, February 3, October 28, 2024 2024 2023 Level 1 Cash equivalents $ 481,491 $ 657,292 $ 269,241 Long-lived assets are measured at fair value on a non-recurring basis for purposes of calculating impairment using the fair value hierarchy of ASC 820. The fair value of the Company’s long-lived assets is calculated using a discounted cash-flow model that used level 3 inputs. In calculating future cash flows, the Company makes estimates regarding future operating results and market rent rates, based on its experience and knowledge of market factors in which the retail location is located. Impairment charges on long-lived assets were $ 3.0 million during the third quarter of Fiscal 2024, primarily related to two stores that relocated and closed before the end of the respective lease-end dates. Impairment charges on long-lived assets were $ 0.8 million during the third quarter of Fiscal 2023, related to declines in revenue and operating results for eight stores. Impairment charges on long-lived assets were $ 11.3 million during the nine month period ended November 2, 2024 , primarily related to a sale-leaseback transaction at one owned store sold below net carrying value and two stores relocated and closed before the end of the respective lease-end dates. Impairment charges on long-lived assets were $ 3.7 million during the nine month period ended October 28, 2023 , related to declines in revenue and operating results for 11 stores, as well as lease asset impairment of $ 2.6 million related to three of those stores. During the nine month period ended November 2, 2024 and the nine month period ended October 28, 2023 , the assets impaired had a remaining carrying value after impairments of $ 61.0 million and $ 75.0 million, respectively. Financial Liabilities The fair values of the Company’s financial liabilities are summarized below: (in thousands) November 2, 2024 February 3, 2024 October 28, 2023 Principal Fair Principal Fair Principal Fair Term Loan Facility $ 1,250,000 $ 1,249,219 $ 937,379 $ 934,450 $ 939,783 $ 935,671 2025 Convertible Notes 156,155 182,166 156,155 169,384 156,155 150,519 2027 Convertible Notes 297,069 395,611 297,069 342,384 297,069 262,202 ABL Line of Credit (a) — — — — — — Total debt (b) $ 1,703,224 $ 1,826,996 $ 1,390,603 $ 1,446,218 $ 1,393,007 $ 1,348,392 (a) To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value, because the interest rate is variable and reflects current market rates, due to its short term nature. (b) The table above excludes finance lease obligations, debt discount and deferred debt costs. The fair values presented herein are based on pertinent information available to management as of the respective period end dates. The estimated fair values of the Company’s debt are classified as Level 2 in the fair value hierarchy, and are based on current market quotes received from inactive markets.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Nov. 02, 2024
Income Tax Disclosure [Abstract]
Income Taxes	7. Income Taxes Income tax expense was $ 27.4 million during the third quarter of Fiscal 2024 compared with $ 18.3 million during the third quarter of Fiscal 2023. The effective tax rate for the third quarter of Fiscal 2024 was 23.2 % compared with 27.4 % during the third quarter of Fiscal 2023. The increase in income tax expense is due to higher pre-tax income. The higher tax rate in the prior period is primarily attributable to the disallowance of certain debt extinguishment costs related to the partial repurchase of the 2025 Convertible Notes and higher tax expense from stock-based compensation. Income tax expense was $ 84.5 million during the nine month period ended November 2, 2024 compared with $ 40.0 million during the nine month period ended October 28, 2023. The effective tax rate for the nine month period ended November 2, 2024 was 25.8 % compared with 26.3 % during the nine month period ended October 28, 2023. The increase in income tax expense is due to higher pre-tax income. The higher tax rate in the prior period is primarily attributable to the disallowance of certain debt extinguishment costs related to the partial repurchase of the 2025 Convertible Notes. Net deferred taxes are as follows: (in thousands) November 2, February 3, October 28, 2024 2024 2023 Deferred tax asset $ 2,131 $ 2,436 $ 2,870 Deferred tax liability 254,011 227,593 237,909 Net deferred tax liability $ 251,880 $ 225,157 $ 235,039 Net deferred tax assets relate to Puerto Rico deferred balances that have a future net benefit for tax purposes. Net deferred tax liabilities primarily relate to intangible assets and depreciation expense where the Company has a future obligation for tax purposes. As of November 2, 2024 , the Company had a deferred tax asset related to net operating losses of $ 5.4 million, inclusive of $ 5.0 million related to state net operating losses that expire at various dates between 2025 and 2041 , as well as $ 0.4 million related to Puerto Rico net operating losses that will expire in 2025 . As of November 2, 2024 , the Company had a deferred tax asset related to tax credit carry-forwards of $ 6.1 million, inclusive of $ 6.0 million of state tax credit carry-forwards, which will begin to expire in 2025 , and $ 0.1 million of deferred tax assets recorded for Puerto Rico alternative minimum tax credits that have an indefinite life . As of November 2, 2024, February 3, 2024 and October 28, 2023 , valuation allowances amounted to $ 7.2 million, $ 11.4 million and $ 10.7 million, respectively, related to state and Puerto Rico net operating losses and state tax credit carry-forwards. The Company believes that it is more likely than not that this portion of state and Puerto Rico net operating losses and state tax credit carry-forwards will not be realized.

Capital Stock

Capital Stock	9 Months Ended
Capital Stock	Nov. 02, 2024
Capital Stock [Abstract]
Capital Stock	8. Capital Stock Treasury Stock The Company accounts for treasury stock under the cost method. Shares Used to Satisfy Tax Withholding During the nine month period ended November 2, 2024 , the Company acquired 69,761 shares of common stock from employees for approximately $ 13.7 million to satisfy their minimum statutory tax withholdings related to the vesting of restricted stock unit awards, which was recorded in the line item “Treasury stock, at cost” on the Company’s Condensed Consolidated Balance Sheets, and the line item “Purchase of treasury shares” on the Company’s Condensed Consolidated Statements of Cash Flows. Share Repurchase Program On August 15, 2023, the Company's Board of Directors authorized the repurchase of up to $ 500 million of common stock, which is authorized to be executed through August 2025 . During the nine month period ended November 2, 2024 , the Company repurchased 795,118 shares of common stock for $ 180.5 million under these repurchase programs, which was recorded in the line item “Treasury stock, at cost” on the Company’s Condensed Consolidated Balance Sheets, and the line item “Purchase of treasury shares” on the Company’s Condensed Consolidated Statements of Cash Flows. As of November 2, 2024, the Company had $ 324.6 million remaining under its share repurchase authorization.

Net Income Per Share

Net Income Per Share	9 Months Ended
Net Income Per Share	Nov. 02, 2024
Earnings Per Share [Abstract]
Net Income Per Share	9. Net Income Per Share Basic net income per share is calculated by dividing net income by the weighted-average number of common shares outstanding. Diluted net income per share is calculated by dividing net income by the weighted-average number of common shares and potentially dilutive securities outstanding during the period using the treasury stock method for the Company’s stock option, restricted stock and restricted stock unit awards, and the if-converted method for the Convertible Notes. The following table presents the computation of basic and diluted net income per share: (in thousands, except per share data) Three Months Ended Nine Months Ended November 2, October 28, November 2, October 28, 2024 2023 2024 2023 Basic net income per share Net income $ 90,597 $ 48,551 $ 242,871 $ 112,191 Weighted average number of common shares – basic 63,563 64,707 63,723 64,852 Net income per common share – basic $ 1.43 $ 0.75 $ 3.81 $ 1.73 Diluted net income per share Net income $ 90,597 $ 48,551 $ 242,871 $ 112,191 Shares for basic and diluted net income per share: Weighted average number of common shares – basic 63,563 64,707 63,723 64,852 Assumed exercise of stock options and vesting of restricted stock 637 95 485 172 Assumed conversion of convertible debt 419 — 187 — Weighted average number of common shares – diluted 64,619 64,802 64,395 65,024 Net income per common share – diluted $ 1.40 $ 0.75 $ 3.77 $ 1.73 Approximately 199,000 and 685,000 shares of the Company’s stock-based compensation grants were excluded from diluted net income per share for the three and nine month periods ended November 2, 2024, respectively, since their effect was anti-dilutive. Approximately 1,820,000 and 1,526,000 shares related to the Company’s stock-based compensation grants were excluded from diluted net income per share for the three and nine month periods ended October 28, 2023, respectively , since their effect was anti-dilutive.

Stock Based Compensation

Stock Based Compensation	9 Months Ended
Stock Based Compensation	Nov. 02, 2024
Share-Based Payment Arrangement [Abstract]
Stock Based Compensation	10. Stock Based Compensation As of November 2, 2024 , there were 3,967,586 shares of common stock available for issuance under the Company’s 2022 Omnibus Incentive Plan. Non-cash stock compensation expense is as follows: (in thousands) Three Months Ended Nine Months Ended November 2, October 28, November 2, October 28, Type of Non-Cash Stock Compensation 2024 2023 2024 2023 Restricted stock unit grants (a) $ 11,698 $ 11,599 $ 32,469 $ 32,143 Stock option grants (a) 5,065 5,417 14,673 14,615 Performance stock unit grants (a) 8,647 4,629 22,154 11,034 Total (b) $ 25,410 $ 21,645 $ 69,296 $ 57,792 (a) Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income. (b) The amounts presented in the table above exclude taxes. For the three and nine month periods ended November 2, 2024 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 4.4 million and $ 12.3 million, respectively. For the three and nine month periods ended October 28, 2023 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 4.1 million and $ 10.9 million, respectively . Stock Options Stock option transactions during the nine month period ended November 2, 2024 are summarized as follows: Number of Weighted Options outstanding, February 3, 2024 1,356,258 $ 197.90 Options granted 378,728 181.10 Options exercised (a) ( 172,168 ) 165.93 Options forfeited ( 71,451 ) 208.17 Options outstanding, November 2, 2024 1,491,367 196.83 (a) Options exercised during the nine month period ended November 2, 2024 had a total intrinsic value of $ 12.0 million . The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of November 2, 2024: Options Weighted Weighted Aggregate Options vested and expected to vest 1,491,367 7.2 $ 196.83 $ 80.1 Options exercisable 732,110 5.6 $ 202.38 $ 38.6 The fair value of each stock option granted during the nine month period ended November 2, 2024 was estimated using the Black Scholes option pricing model using the following assumptions on a weighted average basis: Nine Months Ended November 2, 2024 Risk-free interest rate 4.7 % Expected volatility 42.2 % Expected life (years) 4.0 Contractual life (years) 10.0 Expected dividend yield 0 % Grant date fair value of options issued $ 69.52 The expected dividend yield was based on the Company’s expectation of not paying dividends in the near term. To evaluate its volatility factor, the Company uses the historical volatility of its stock price over the expected life of the options. The risk free interest rate was based on the U.S. Treasury rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the awards being valued. The expected life of the options was estimated using historical exercise rates. Restricted Stock Units Restricted stock unit transactions during the nine month period ended November 2, 2024 are summarized as follows: Number of Weighted Non-vested awards outstanding, February 3, 2024 570,952 $ 204.97 Awards granted 315,920 184.47 Awards vested (a) ( 164,809 ) 225.24 Awards forfeited ( 48,605 ) 194.98 Non-vested awards outstanding, November 2, 2024 673,458 191.11 (a) Restricted stock units vested during the nine month period ended November 2, 2024 had a total intrinsic value of $3 1.3 million . The fair value of each share of restricted stock granted during the nine month period ended November 2, 2024 was based upon the closing price of the Company’s common stock on the grant date. Performance Stock Units The Company grants performance-based restricted stock units to its senior executives. Vesting of the performance stock units granted in Fiscal 2021 is based on continued service and the achievement of pre-established adjusted EBIT margin expansion and sales compounded annual growth rate (CAGR) goals (each weighted equally) over a three-year performance period. Vesting of the performance stock units granted in Fiscal 2022, Fiscal 2023, and Fiscal 2024 are based on continued service and the achievement of pre-established adjusted net income per share growth over a three-year performance period. Based on the Company’s achievement of these goals, each award may be earned up to 200 % of the target award. In the event that actual performance is below threshold, no award will be made. Compensation costs recognized on the performance stock units are adjusted, as applicable, for performance above or below the target specified in the award. Performance stock unit transactions during the nine month period ended November 2, 2024 are summarized as follows: Number of Weighted Non-vested awards outstanding, February 3, 2024 226,917 $ 217.29 Awards granted 124,821 185.19 Awards vested (a) ( 44,535 ) 319.32 Awards forfeited ( 11,820 ) 216.38 Non-vested awards outstanding, November 2, 2024 295,383 188.38 (a) Performance-based stock awards vested during the nine month period ended November 2, 2024 had a total intrinsic value of $ 10.1 million.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Nov. 02, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies Legal In the course of business, the Company is party to class or collective actions alleging violations of federal and state wage and hour and other labor statutes, representative claims under the California Private Attorneys’ General Act and various other lawsuits and regulatory proceedings from time to time including, among others, commercial, product, employee, customer, intellectual property and other claims. Actions against us are in various procedural stages. Many of these proceedings raise factual and legal issues and are subject to uncertainties. While no assurance can be given as to the ultimate outcome of these matters, the Company believes that the final resolution of these actions will not have a material adverse effect on the Company’s results of operations, financial position, liquidity or capital resources. Letters of Credit The Company had letters of credit arrangements with various banks in the aggregate amount of $ 52.5 million, $ 75.8 million and $ 76.0 million as of November 2, 2024, February 3, 2024 and October 28, 2023, respectively. Among these arrangements, as of November 2, 2024, February 3, 2024 and October 28, 2023 , the Company had letters of credit outstanding in the amount of $ 51.9 million, $ 75.8 million and $ 75.8 million, respectively, guaranteeing performance under various lease agreements, insurance contracts, and utility agreements. In addition, the Company had outstanding letters of credit arrangements in the amounts of $ 0.6 million and $ 0.2 million at November 2, 2024 and October 28, 2023 , respectively, related to certain merchandising agreements, and no ne at February 3, 2024. Based on the terms of the agreement governing the ABL Line of Credit, the Company had the ability to enter into letters of credit up to $ 160.0 million, $ 174.2 million and $ 174.0 million as of November 2, 2024, February 3, 2024 and October 28, 2023, respectively. Purchase Commitments The Company had $ 1,747.7 million of purchase commitments related to goods that were not received as of November 2, 2024.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Nov. 02, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation As of November 2, 2024, Burlington Stores, Inc., a Delaware corporation (collectively with its subsidiaries, the Company), through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 1,103 retail stores. These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2024 (Fiscal 2023 10-K). The balance sheet at February 3, 2024 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2023 10-K. Because the Company’s business is seasonal in nature, the operating results for the three and nine month periods ended November 2, 2024 are not necessarily indicative of results for the fiscal year. Accounting policies followed by the Company are described in Note 1, “Summary of Significant Accounting Policies,” included in Part II, Item 8 of the Fiscal 2023 10-K.
Fiscal Year	Fiscal Year The Company defines its fiscal year as the 52 or 53-week period ending on the Saturday closest to January 31. Fiscal 2024 is defined as the 52-week year ending February 1, 2025, and Fiscal 2023 is defined as the 53-week year ended February 3, 2024. The first, second, and third quarters of Fiscal 2024 and Fiscal 2023 each consist of 13 weeks.
Recently Adopted Accounting Standards	Recently Adopted Accounting Standards There were no new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements and notes thereto during the three and nine month periods ended November 2, 2024. In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" (ASU 2023-07) to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The standard is effective for annual reporting periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. The Company is currently evaluating the impact of ASU 2023-07 on its disclosures in the consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topics 740): Improvements to Income Tax Disclosures" (ASU 2023-09) to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for annual reporting periods beginning after December 15, 2024, with early adoption permitted and can be applied on either a prospective or retroactive basis. The Company is currently evaluating the impact of ASU 2023-09 on its disclosures in the consolidated financial statements.

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	9 Months Ended
Stockholders’ Equity (Tables)	Nov. 02, 2024
Stockholders' Equity Note [Abstract]
Company's Stockholders Equity	Activity for the three and nine month periods ended November 2, 2024 and October 28, 2023 in the Company’s stockholders’ equity is summarized below: (in thousands, except share data) Common Stock Additional Accumulated Accumulated Treasury Stock Shares Amount Capital Earnings Income Shares Amount Total Balance at February 3, 2024 82,399,577 $ 8 $ 2,118,356 $ 984,064 $ 33,533 ( 18,435,206 ) $ ( 2,139,029 ) $ 996,932 Net income — — — 78,514 — — — 78,514 Stock options exercised 55,688 — 8,472 — — — — 8,472 Shares used for tax withholding — — — — — ( 63,407 ) ( 12,222 ) ( 12,222 ) Shares purchased as part of publicly announced program, inclusive of $ 0.4 million related to excise tax — — — — — ( 312,238 ) ( 63,769 ) ( 63,769 ) Vesting of restricted shares 181,607 — — — — — — — Stock based compensation — — 19,107 — — — — 19,107 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 2.8 million — — — — 7,735 — — 7,735 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 1.2 million — — — — ( 3,343 ) — — ( 3,343 ) Balance at May 4, 2024 82,636,872 8 2,145,935 1,062,578 37,925 ( 18,810,851 ) ( 2,215,020 ) 1,031,426 Net income — — — 73,760 — — — 73,760 Stock options exercised 89,961 — 15,393 — — — — 15,393 Shares used for tax withholding — — — — — ( 3,790 ) ( 916 ) ( 916 ) Shares purchased as part of publicly announced program, inclusive of $ 0.5 million related to excise tax — — — — — ( 269,508 ) ( 61,721 ) ( 61,721 ) Vesting of restricted shares 19,674 — — — — — — — Stock based compensation — — 24,779 — — — — 24,779 Unrealized losses on interest rate derivative contracts, net of related taxes of $ 3.3 million — — — — ( 9,037 ) — — ( 9,037 ) Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 1.2 million — — — — ( 3,347 ) — — ( 3,347 ) Balance at August 3, 2024 82,746,507 8 2,186,107 1,136,338 25,541 ( 19,084,149 ) ( 2,277,657 ) 1,070,337 Net income — — — 90,597 — — — 90,597 Stock options exercised 26,519 — 4,707 — — — — 4,707 Shares used for tax withholding — — — — — ( 2,564 ) ( 601 ) ( 601 ) Shares purchased as part of publicly announced program, inclusive of $ 0.5 million related to excise tax — — — — — ( 213,372 ) ( 56,382 ) ( 56,382 ) Vesting of restricted shares 8,063 — — — — — — — Stock based compensation — — 25,410 — — — — 25,410 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 5.8 million — — — — 15,895 — — 15,895 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 1.3 million — — — — ( 3,476 ) — — ( 3,476 ) Balance at November 2, 2024 82,781,089 $ 8 $ 2,216,224 $ 1,226,935 $ 37,960 ( 19,300,085 ) $ ( 2,334,640 ) $ 1,146,487 (in thousands, except share data) Common Stock Additional Accumulated Accumulated Treasury Stock Shares Amount Capital Earnings Income Shares Amount Total Balance at January 28, 2023 82,037,994 $ 8 $ 2,015,625 $ 644,415 $ 28,748 ( 17,018,281 ) $ ( 1,893,891 ) $ 794,905 Net income — — — 32,748 — — — 32,748 Stock options exercised 90,971 — 10,764 — — — — 10,764 Shares used for tax withholding — — — — — ( 9,457 ) ( 1,962 ) ( 1,962 ) Shares purchased as part of publicly announced program, inclusive of $ 0.4 million related to excise tax — — — — — ( 245,414 ) ( 51,823 ) ( 51,823 ) Vesting of restricted shares 28,536 — — — — — — — Stock based compensation — — 16,722 — — — — 16,722 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 0.3 million — — — — 947 — — 947 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 0.3 million — — — — ( 827 ) — — ( 827 ) Balance at April 29, 2023 82,157,501 8 2,043,111 677,163 28,868 ( 17,273,152 ) ( 1,947,676 ) 801,474 Net income — — — 30,892 — — — 30,892 Stock options exercised 15,236 — 1,512 — — — — 1,512 Shares used for tax withholding — — — — — ( 48,938 ) ( 8,626 ) ( 8,626 ) Shares purchased as part of publicly announced program, inclusive of $ 0.1 million related to excise tax — — — — — ( 154,358 ) ( 26,104 ) ( 26,104 ) Vesting of restricted shares 153,739 — — — — — — — Stock based compensation — — 19,425 — — — — 19,425 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 3.1 million — — — — 8,465 — — 8,465 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 0.4 million — — — — ( 1,179 ) — — ( 1,179 ) Balance at July 29, 2023 82,326,476 8 2,064,048 708,055 36,154 ( 17,476,448 ) ( 1,982,406 ) 825,859 Net income — — — 48,551 — — — 48,551 Stock options exercised 8,101 — 1,105 — — — — 1,105 Shares used for tax withholding — — — — — ( 3,633 ) ( 537 ) ( 537 ) Shares purchased as part of publicly announced program, inclusive of $ 0.5 million related to excise tax — — — — — ( 348,948 ) ( 52,379 ) ( 52,379 ) Vesting of restricted shares 19,714 — — — — — — — Stock based compensation — — 21,645 — — — — 21,645 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 2.8 million — — — — 7,618 — — 7,618 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 0.5 million — — — — ( 1,386 ) — — ( 1,386 ) Balance at October 28, 2023 82,354,291 $ 8 $ 2,086,798 $ 756,606 $ 42,386 ( 17,829,029 ) $ ( 2,035,322 ) $ 850,476

Lease Commitments (Tables)

Lease Commitments (Tables)	9 Months Ended
Lease Commitments (Tables)	Nov. 02, 2024
Leases [Abstract]
Future Lease Payments	The following is a schedule of the Company’s future lease payments: (in thousands) Fiscal Year Operating Finance 2024 (remainder) $ 100,447 $ 869 2025 665,226 3,526 2026 625,286 3,640 2027 583,996 3,640 2028 535,944 3,447 Thereafter 1,954,979 20,787 Total future minimum lease payments 4,465,878 35,909 Amount representing interest ( 939,922 ) ( 10,404 ) Total lease liabilities 3,525,956 25,505 Less: current portion of lease liabilities ( 401,840 ) ( 2,168 ) Total long term lease liabilities $ 3,124,116 $ 23,337 Weighted average discount rate 6.0 % 5.5 % Weighted average remaining lease term (years) 7.8 12.2
Schedule of Net Lease Costs	The following is a schedule of net lease costs for the periods indicated: (in thousands) Three Months Ended Nine Months Ended November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Finance lease cost: Amortization of finance lease asset (a) $ 566 $ 877 $ 2,007 $ 2,630 Interest on lease liabilities (b) 351 454 1,096 1,425 Operating lease cost (c) 158,211 147,270 466,239 427,072 Variable lease cost (c) 63,652 58,915 186,204 168,864 Total lease cost 222,780 207,516 655,546 599,991 Impairment (gain) on sale and leaseback transaction (d) — — 8,210 ( 1,958 ) Less all rental income (e) ( 1,261 ) ( 1,383 ) ( 3,974 ) ( 4,224 ) Total net rent expense (f) $ 221,519 $ 206,133 $ 659,782 $ 593,809 (a) Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income. (b) Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income. (c) Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income. (d) Impairment included in the line item "Impairment charges - long-lived assets" and gain included in line item “Other income - net” in the Company’s Condensed Consolidated Statements of Income. (e) Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income. (f) Excludes an immaterial amount of short-term lease cost.
Schedule of Supplemental Cash Flow Disclosures Related to Leases	Supplemental cash flow disclosures related to leases are as follows: (in thousands) Nine Months Ended November 2, 2024 October 28, 2023 Cash paid for amounts included in the measurement of lease liabilities: Cash payments arising from operating lease liabilities (a) $ 471,192 $ 431,200 Cash payments for the principal portion of finance lease liabilities (b) $ 2,041 $ 2,975 Cash payments for the interest portion of finance lease liabilities (a) $ 1,096 $ 1,425 Supplemental non-cash information: Operating lease liabilities arising from obtaining right-of-use assets $ 531,539 $ 494,327 (a) Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. (b) Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.

Long Term Debt (Tables)

Long Term Debt (Tables)	9 Months Ended
Long Term Debt (Tables)	Nov. 02, 2024
Debt Disclosure [Abstract]
Long Term Debt	Long term debt consists of: (in thousands) November 2, February 3, October 28, 2024 2024 2023 Senior secured term loan facility, adjusted SOFR (with a floor of 0.00 %) plus 1.75 %, matures on September 24, 2031 $ 1,241,737 $ 933,355 $ 935,507 Convertible senior notes, 2.25 %, mature on April 15, 2025 156,155 156,155 156,155 Convertible senior notes, 1.25 %, mature on December 15, 2027 297,069 297,069 297,069 ABL senior secured revolving facility, SOFR plus spread based on average outstanding balance, matures on December 22, 2026 — — — Finance lease obligations 25,505 29,069 30,471 Unamortized deferred financing costs ( 6,931 ) ( 7,003 ) ( 7,614 ) Total debt 1,713,535 1,408,645 1,411,588 Less: current maturities ( 170,823 ) ( 13,703 ) ( 13,970 ) Long term debt, net of current maturities $ 1,542,712 $ 1,394,942 $ 1,397,618

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	9 Months Ended
Derivative Instruments and Hedging Activities (Tables)	Nov. 02, 2024
Fair Value of Company's Derivative Financial Instruments on Gross Basis as well as Classification	The table below presents the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets: (in thousands) Fair Values of Derivative Instruments November 2, 2024 February 3, 2024 October 28, 2023 Derivatives Designated as Hedging Instruments Balance Fair Balance Fair Balance Fair Interest rate swap contracts Other assets $ 38,143 Other assets $ 29,075 Other assets $ 43,031
Summary of Unrealized Gains and Losses Deferred to Accumulated Other Comprehensive Income	The following table presents the unrealized gains and losses deferred to accumulated other comprehensive income resulting from the Company’s derivative financial instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Interest Rate Derivatives: November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Unrealized gains, before taxes $ 21,696 $ 10,416 $ 19,931 $ 23,269 Income tax benefit ( 5,801 ) ( 2,798 ) ( 5,338 ) ( 6,240 ) Unrealized gains, net of taxes $ 15,895 $ 7,618 $ 14,593 $ 17,029
Reclassification of Gains and Losses from Accumulated Other Comprehensive Income into Earnings	The following table presents information about the reclassification of gains and losses from accumulated other comprehensive income into earnings related to the Company’s derivative instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Component of Earnings: November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Interest benefit $ ( 4,745 ) $ ( 1,892 ) $ ( 13,876 ) $ ( 4,631 ) Income tax expense 1,269 506 3,710 1,240 Net reclassification into earnings $ ( 3,476 ) $ ( 1,386 ) $ ( 10,166 ) $ ( 3,391 )
Derivatives Designated as Hedging Instruments
Outstanding Interest Rate Derivatives in Qualifying Hedging Relationships	As of November 2, 2024, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk: Interest Rate Derivative Number of Notional Aggregate Principal Amount Interest Swap Rate Maturity Date Interest rate swap contract Two $ 800.0 million 2.83 % - 3.37 % September 24, 2031

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Nov. 02, 2024
Fair Value Disclosures [Abstract]
Fair Values of Financial Assets and Hierarchy of Level of Inputs	The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of November 2, 2024, February 3, 2024 and October 28, 2023 are summarized below: (in thousands) Fair Value Measurements at November 2, February 3, October 28, 2024 2024 2023 Level 1 Cash equivalents $ 481,491 $ 657,292 $ 269,241
Fair Values of Financial Liabilities	The fair values of the Company’s financial liabilities are summarized below: (in thousands) November 2, 2024 February 3, 2024 October 28, 2023 Principal Fair Principal Fair Principal Fair Term Loan Facility $ 1,250,000 $ 1,249,219 $ 937,379 $ 934,450 $ 939,783 $ 935,671 2025 Convertible Notes 156,155 182,166 156,155 169,384 156,155 150,519 2027 Convertible Notes 297,069 395,611 297,069 342,384 297,069 262,202 ABL Line of Credit (a) — — — — — — Total debt (b) $ 1,703,224 $ 1,826,996 $ 1,390,603 $ 1,446,218 $ 1,393,007 $ 1,348,392 (a) To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value, because the interest rate is variable and reflects current market rates, due to its short term nature. (b) The table above excludes finance lease obligations, debt discount and deferred debt costs.

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
Income Taxes (Tables)	Nov. 02, 2024
Income Tax Disclosure [Abstract]
Net Deferred Taxes	Net deferred taxes are as follows: (in thousands) November 2, February 3, October 28, 2024 2024 2023 Deferred tax asset $ 2,131 $ 2,436 $ 2,870 Deferred tax liability 254,011 227,593 237,909 Net deferred tax liability $ 251,880 $ 225,157 $ 235,039

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
Net Income Per Share (Tables)	Nov. 02, 2024
Earnings Per Share [Abstract]
Computation of Basic and Diluted Net Income per Share	The following table presents the computation of basic and diluted net income per share: (in thousands, except per share data) Three Months Ended Nine Months Ended November 2, October 28, November 2, October 28, 2024 2023 2024 2023 Basic net income per share Net income $ 90,597 $ 48,551 $ 242,871 $ 112,191 Weighted average number of common shares – basic 63,563 64,707 63,723 64,852 Net income per common share – basic $ 1.43 $ 0.75 $ 3.81 $ 1.73 Diluted net income per share Net income $ 90,597 $ 48,551 $ 242,871 $ 112,191 Shares for basic and diluted net income per share: Weighted average number of common shares – basic 63,563 64,707 63,723 64,852 Assumed exercise of stock options and vesting of restricted stock 637 95 485 172 Assumed conversion of convertible debt 419 — 187 — Weighted average number of common shares – diluted 64,619 64,802 64,395 65,024 Net income per common share – diluted $ 1.40 $ 0.75 $ 3.77 $ 1.73

Stock Based Compensation (Table

Stock Based Compensation (Tables)	9 Months Ended
Stock Based Compensation (Tables)	Nov. 02, 2024
Share-Based Payment Arrangement [Abstract]
Non-Cash Stock Compensation Expense	Non-cash stock compensation expense is as follows: (in thousands) Three Months Ended Nine Months Ended November 2, October 28, November 2, October 28, Type of Non-Cash Stock Compensation 2024 2023 2024 2023 Restricted stock unit grants (a) $ 11,698 $ 11,599 $ 32,469 $ 32,143 Stock option grants (a) 5,065 5,417 14,673 14,615 Performance stock unit grants (a) 8,647 4,629 22,154 11,034 Total (b) $ 25,410 $ 21,645 $ 69,296 $ 57,792 (a) Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income. (b) The amounts presented in the table above exclude taxes. For the three and nine month periods ended November 2, 2024 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 4.4 million and $ 12.3 million, respectively. For the three and nine month periods ended October 28, 2023 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 4.1 million and $ 10.9 million, respectively .
Stock Option Transactions	Stock option transactions during the nine month period ended November 2, 2024 are summarized as follows: Number of Weighted Options outstanding, February 3, 2024 1,356,258 $ 197.90 Options granted 378,728 181.10 Options exercised (a) ( 172,168 ) 165.93 Options forfeited ( 71,451 ) 208.17 Options outstanding, November 2, 2024 1,491,367 196.83 (a) Options exercised during the nine month period ended November 2, 2024 had a total intrinsic value of $ 12.0 million .
Stock Options Vested and Expected to Vest	The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of November 2, 2024: Options Weighted Weighted Aggregate Options vested and expected to vest 1,491,367 7.2 $ 196.83 $ 80.1 Options exercisable 732,110 5.6 $ 202.38 $ 38.6
Weighted Average Assumptions Used to Estimate Fair Value of Each Stock Option Granted	The fair value of each stock option granted during the nine month period ended November 2, 2024 was estimated using the Black Scholes option pricing model using the following assumptions on a weighted average basis: Nine Months Ended November 2, 2024 Risk-free interest rate 4.7 % Expected volatility 42.2 % Expected life (years) 4.0 Contractual life (years) 10.0 Expected dividend yield 0 % Grant date fair value of options issued $ 69.52
Award Grant and Vesting Transactions	Restricted stock unit transactions during the nine month period ended November 2, 2024 are summarized as follows: Number of Weighted Non-vested awards outstanding, February 3, 2024 570,952 $ 204.97 Awards granted 315,920 184.47 Awards vested (a) ( 164,809 ) 225.24 Awards forfeited ( 48,605 ) 194.98 Non-vested awards outstanding, November 2, 2024 673,458 191.11 (a) Restricted stock units vested during the nine month period ended November 2, 2024 had a total intrinsic value of $3 1.3 million .
Performance Stock Unit Transactions	Performance stock unit transactions during the nine month period ended November 2, 2024 are summarized as follows: Number of Weighted Non-vested awards outstanding, February 3, 2024 226,917 $ 217.29 Awards granted 124,821 185.19 Awards vested (a) ( 44,535 ) 319.32 Awards forfeited ( 11,820 ) 216.38 Non-vested awards outstanding, November 2, 2024 295,383 188.38 (a) Performance-based stock awards vested during the nine month period ended November 2, 2024 had a total intrinsic value of $ 10.1 million.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Detail)	Nov. 02, 2024 Store
Summary Of Significant Accounting Policies [Line Items]
Number of stores operated	1,103

Company's Stockholders' Equity

Company's Stockholders' Equity (Detail) - USD ($) $ in Thousands		3 Months Ended						9 Months Ended
		Nov. 02, 2024	Aug. 03, 2024	May 04, 2024	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Nov. 02, 2024	Oct. 28, 2023
Balance at beginning of period		$ 1,070,337	$ 1,031,426	$ 996,932	$ 825,859	$ 801,474	$ 794,905	$ 996,932	$ 794,905
Net income		90,597	73,760	78,514	48,551	30,892	32,748	$ 242,871	$ 112,191
Stock options exercised		4,707	15,393	8,472	1,105	1,512	10,764
Stock options exercised (in shares)	[1]							172,168
Shares used for tax withholding		(601)	(916)	(12,222)	(537)	(8,626)	(1,962)
Shares purchased as part of publicly announced program		$ (56,382)	(61,721)	(63,769)	$ (52,379)	(26,104)	(51,823)
Vesting of restricted shares		637,000			95,000			485,000	172,000
Stock based compensation		$ 25,410	24,779	19,107	$ 21,645	19,425	16,722
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit		15,895	(9,037)	7,735	7,618	8,465	947	$ 14,593	$ 17,029
Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes		(3,476)	(3,347)	(3,343)	(1,386)	(1,179)	(827)	(10,166)	(3,391)
Balance at end of period		1,146,487	1,070,337	1,031,426	850,476	825,859	801,474	1,146,487	850,476
Common Stock
Balance at beginning of period		$ 8	$ 8	$ 8	$ 8	$ 8	$ 8	$ 8	$ 8
Balance at beginning of period (in shares)		82,746,507	82,636,872	82,399,577	82,326,476	82,157,501	82,037,994	82,399,577	82,037,994
Stock options exercised (in shares)		26,519	89,961	55,688	8,101	15,236	90,971
Vesting of restricted shares		8,063	19,674	181,607	19,714	153,739	28,536
Balance at end of period		$ 8	$ 8	$ 8	$ 8	$ 8	$ 8	$ 8	$ 8
Balance at end of period (in shares)		82,781,089	82,746,507	82,636,872	82,354,291	82,326,476	82,157,501	82,781,089	82,354,291
Additional Paid-in Capital
Balance at beginning of period		$ 2,186,107	$ 2,145,935	$ 2,118,356	$ 2,064,048	$ 2,043,111	$ 2,015,625	$ 2,118,356	$ 2,015,625
Stock options exercised		4,707	15,393	8,472	1,105	1,512	10,764
Stock based compensation		25,410	24,779	19,107	21,645	19,425	16,722
Balance at end of period		2,216,224	2,186,107	2,145,935	2,086,798	2,064,048	2,043,111	2,216,224	2,086,798
Accumulated Earnings
Balance at beginning of period		1,136,338	1,062,578	984,064	708,055	677,163	644,415	984,064	644,415
Net income		90,597	73,760	78,514	48,551	30,892	32,748
Balance at end of period		1,226,935	1,136,338	1,062,578	756,606	708,055	677,163	1,226,935	756,606
Accumulated Other Comprehensive Income
Balance at beginning of period		25,541	37,925	33,533	36,154	28,868	28,748	33,533	28,748
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit		15,895	(9,037)	7,735	7,618	8,465	947
Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes		(3,476)	(3,347)	(3,343)	(1,386)	(1,179)	(827)
Balance at end of period		37,960	25,541	37,925	42,386	36,154	28,868	37,960	42,386
Treasury Stock
Balance at beginning of period		$ (2,277,657)	$ (2,215,020)	$ (2,139,029)	$ (1,982,406)	$ (1,947,676)	$ (1,893,891)	$ (2,139,029)	$ (1,893,891)
Balance at beginning of period (in shares)		(19,084,149)	(18,810,851)	(18,435,206)	(17,476,448)	(17,273,152)	(17,018,281)	(18,435,206)	(17,018,281)
Shares used for tax withholding		$ (601)	$ (916)	$ (12,222)	$ (537)	$ (8,626)	$ (1,962)	$ (13,700)
Shares used for tax withholding (in shares)		(2,564)	(3,790)	(63,407)	(3,633)	(48,938)	(9,457)	(69,761)
Shares purchased as part of publicly announced program		$ (56,382)	$ (61,721)	$ (63,769)	$ (52,379)	$ (26,104)	$ (51,823)
Shares purchased as part of publicly announced program, (in shares)		(213,372)	(269,508)	(312,238)	(348,948)	(154,358)	(245,414)
Balance at end of period		$ (2,334,640)	$ (2,277,657)	$ (2,215,020)	$ (2,035,322)	$ (1,982,406)	$ (1,947,676)	$ (2,334,640)	$ (2,035,322)
Balance at end of period (in shares)		(19,300,085)	(19,084,149)	(18,810,851)	(17,829,029)	(17,476,448)	(17,273,152)	(19,300,085)	(17,829,029)

[1] Options exercised during the nine month period ended November 2, 2024 had a total intrinsic value of $ 12.0 million .

Company's Stockholders' Equit_2

Company's Stockholders' Equity (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended
	Nov. 02, 2024	Aug. 03, 2024	May 04, 2024	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023
Statement of Stockholders' Equity [Abstract]
Excise tax	$ 0.5	$ 0.5	$ 0.4	$ 0.5	$ 0.1	$ 0.4
Unrealized gains (losses) on interest rate derivative contracts, Tax	5.8	3.3	2.8	2.8	3.1	0.3
Amount reclassified from accumulated other comprehensive income (loss) into earnings on Interest Rate Cap Contracts, Tax	$ 1.3	$ 1.2	$ 1.2	$ 0.5	$ 0.4	$ 0.3

Lease Commitments - Additional

Lease Commitments - Additional Information (Detail) $ in Millions	9 Months Ended
	Nov. 02, 2024 USD ($) Store
Future Minimum Payments Receivable [Line Items]
Operating and finance leases, expiration period	30 years
Leases renewal option	5 years
Accrued lease liability \| $	$ 525.1
Number of store committed to open or relocate but has not yet taken possession \| Store	49

Future Lease Payments (Detail)

Future Lease Payments (Detail) - USD ($) $ in Thousands	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Operating Leases
2024 (remainder)	$ 100,447
2025	665,226
2026	625,286
2027	583,996
2028	535,944
Thereafter	1,954,979
Total future minimum lease payments	4,465,878
Amount representing interest	(939,922)
Total lease liabilities	3,525,956
Less: current portion of lease liabilities	(401,840)	$ (411,395)	$ (412,303)
Total long term lease liabilities	$ 3,124,116	2,984,794	2,982,549
Weighted average discount rate	6%
Weighted average remaining lease term (years)	7 years 9 months 18 days
Finance Leases
2024 (remainder)	$ 869
2025	3,526
2026	3,640
2027	3,640
2028	3,447
Thereafter	20,787
Total future minimum lease payments	35,909
Amount representing interest	(10,404)
Total lease liabilities	$ 25,505	$ 29,069	$ 30,471
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Long Term Debt And Capital Lease Obligations Current and Noncurrent	Long Term Debt And Capital Lease Obligations Current and Noncurrent	Long Term Debt And Capital Lease Obligations Current and Noncurrent
Less: current portion of lease liabilities	$ (2,168)
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Long-Term Debt and Lease Obligation, Current
Total long term lease liabilities	$ 23,337
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Long-Term Debt and Lease Obligation
Weighted average discount rate	5.50%
Weighted average remaining lease term (years)	12 years 2 months 12 days

Schedule of Net Lease Costs (De

Schedule of Net Lease Costs (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Finance lease cost:
Amortization of finance lease asset	[1]	$ 566	$ 877	$ 2,007	$ 2,630
Interest on lease liabilities	[2]	351	454	1,096	1,425
Operating lease cost	[3]	158,211	147,270	466,239	427,072
Variable lease cost	[3]	63,652	58,915	186,204	168,864
Total lease cost		222,780	207,516	655,546	599,991
Impairment (gain) on sale and leaseback transaction	[4]			8,210	(1,958)
Less all rental income	[5]	(1,261)	(1,383)	(3,974)	(4,224)
Total net rent expense	[6]	$ 221,519	$ 206,133	$ 659,782	$ 593,809

[1] Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income. Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income. Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income. Impairment included in the line item "Impairment charges - long-lived assets" and gain included in line item “Other income - net” in the Company’s Condensed Consolidated Statements of Income. Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income. Excludes an immaterial amount of short-term lease cost.

Schedule of Supplemental Cash F

Schedule of Supplemental Cash Flow Disclosures Related to Leases (Details) - USD ($) $ in Thousands		9 Months Ended
		Nov. 02, 2024	Oct. 28, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Cash payments arising from operating lease liabilities	[1]	$ 471,192	$ 431,200
Cash payments for the principal portion of finance lease liabilities	[2]	2,041	2,975
Cash payments for the interest portion of finance lease liabilities	[1]	1,096	1,425
Operating lease liabilities arising from obtaining right-of-use assets		$ 531,539	$ 494,327

[1] Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.

Long-Term Debt (Detail)

Long-Term Debt (Detail) - USD ($) $ in Thousands	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Debt Instrument [Line Items]
Finance lease obligations	$ 25,505	$ 29,069	$ 30,471
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Long term debt and capital lease obligations current and noncurrent	Long term debt and capital lease obligations current and noncurrent	Long term debt and capital lease obligations current and noncurrent
Unamortized deferred financing costs	$ (6,931)	$ (7,003)	$ (7,614)
Total debt	1,713,535	1,408,645	1,411,588
Less: current maturities	(170,823)	(13,703)	(13,970)
Long term debt, net of current maturities	1,542,712	1,394,942	1,397,618
Senior Secured Term Loan Facilities
Debt Instrument [Line Items]
Long Term Debt	1,241,737	933,355	935,507
Convertible Senior Notes 2.25% Due April 15 2025
Debt Instrument [Line Items]
Long Term Debt	156,155	156,155	156,155
Convertible Senior Notes 1.25% Due December 15 2027
Debt Instrument [Line Items]
Long Term Debt	$ 297,069	$ 297,069	$ 297,069

Long-Term Debt (Parenthetical)

Long-Term Debt (Parenthetical) (Detail)		9 Months Ended		12 Months Ended
Long-Term Debt (Parenthetical) (Detail)	Apr. 16, 2020	Nov. 02, 2024	Oct. 28, 2023	Feb. 03, 2024
Senior Secured Term Loan Facilities
Debt Instrument [Line Items]
Long-Term Debt, maturity date		Sep. 24, 2031	Sep. 24, 2031	Sep. 24, 2031
Convertible Senior Notes 2.25% Due April 15 2025
Debt Instrument [Line Items]
Long-Term Debt, maturity date		Apr. 15, 2025	Apr. 15, 2025	Apr. 15, 2025
Long-Term Debt, interest rate		2.25%	2.25%	2.25%
Convertible Senior Notes 1.25% Due December 15 2027
Debt Instrument [Line Items]
Long-Term Debt, maturity date		Dec. 15, 2027	Dec. 15, 2027	Dec. 15, 2027
Long-Term Debt, interest rate		1.25%	1.25%	1.25%
Convertible Senior Notes
Debt Instrument [Line Items]
Long-Term Debt, maturity date	Apr. 15, 2025
Long-Term Debt, interest rate	2.25%
ABL senior secured revolving facility
Debt Instrument [Line Items]
Long-Term Debt, maturity date		Dec. 22, 2026	Dec. 22, 2026	Dec. 22, 2026
Secured Overnight Financing Rate Floor \| Senior Secured Term Loan Facilities
Debt Instrument [Line Items]
Long-Term Debt, interest rate		0%	0%	0%
Secured Overnight Financing Rate (SOFR) \| Senior Secured Term Loan Facilities
Debt Instrument [Line Items]
Long-Term Debt, interest rate		1.75%	1.75%	1.75%

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail)

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 24, 2024 USD ($)

Sep. 23, 2024

Sep. 12, 2023 USD ($) $ / shares shares

Apr. 16, 2020 USD ($) $ / shares

Nov. 02, 2024 USD ($) shares

Oct. 28, 2023 USD ($)

Apr. 29, 2023 USD ($)

Nov. 02, 2024 USD ($) shares

Oct. 28, 2023 USD ($)

Feb. 03, 2024 USD ($)

Jun. 26, 2023 USD ($)

Jun. 25, 2023 USD ($)

Debt Instrument [Line Items]

Loss on extinguishment of debt

$ (1,412,000)

$ (13,630,000)

$ (1,412,000)

$ (38,274,000)

Assumed conversion of convertible debt | shares

419,000

187,000

Letters of credit, outstanding amount

$ 52,500,000

$ 76,000,000

$ 52,500,000

$ 76,000,000

$ 75,800,000

Senior Secured Term Loan Facilities

Debt Instrument [Line Items]

Debt instrument maturity date

Sep. 24, 2031

Interest rate

6.40%

7.40%

6.40%

7.40%

Long Term Debt

$ 1,241,737,000

$ 935,507,000

$ 1,241,737,000

$ 935,507,000

$ 933,355,000

Convertible Senior Notes

Debt Instrument [Line Items]

Loss on extinguishment of debt

$ 24,600,000

Debt instrument maturity date

Apr. 15, 2025

Interest rate

2.80%

Long-Term Debt, interest rate

2.25%

Debt instrument frequency of periodic payments

semi-annually

Debt instrument, conversion ratio

4.5418

Debt instrument, principal amount for conversion

$ 1,000,000

Debt conversion, aggregate principal amount of convertible debt

$ 241,200,000

110,300,000

Debt conversion, converted instrument, in cash

$ 133,300,000

Debt instrument, conversion price | $ / shares

$ 220.18

Debt instrument, conversion premium

32.50%

Share price | $ / shares

$ 166.17

Debt instrument, convertible, stock price trigger

130%

Debt instrument, redemption price, percentage

100%

Debt instrument repurchase percentage on conditional basis

100%

New Convertible Senior Notes

Debt Instrument [Line Items]

Loss on extinguishment of debt

$ 13,600,000

Debt instrument maturity date

Dec. 15, 2027

Conversion of convertible securities contingent conditions | shares

1,911,372

Interest rate

1.70%

Long-Term Debt, interest rate

1.25%

Debt instrument frequency of periodic payments

semi-annually

Debt instrument, conversion ratio

4.856

Debt instrument, principal amount for conversion

$ 1,000,000

Debt conversion, aggregate principal amount of convertible debt

$ 255,000,000

Debt instrument, conversion price | $ / shares

$ 205.93

Debt instrument, conversion premium

32.50%

Share price | $ / shares

$ 155.42

Debt instrument, convertible, stock price trigger

130%

Debt instrument, redemption price, percentage

100%

Debt instrument repurchase percentage on conditional basis

100%

Long Term Debt

$ 297,100,000

Assumed conversion of convertible debt | shares

1,422,568

New Convertible Senior Notes | Private Placement

Debt Instrument [Line Items]

Long Term Debt

$ 42,100,000

ABL senior secured revolving facility

Debt Instrument [Line Items]

Debt instrument maturity date

Dec. 22, 2026

Line of Credit Facility, maximum borrowing capacity

900,000,000

$ 900,000,000

Line of Credit Facility, amount available

847,500,000

824,000,000

847,500,000

$ 824,000,000

Line of Credit Facility, amount outstanding during period

$ 0

Letters of credit, outstanding amount

$ 250,000,000

$ 150,000,000

ABL senior secured revolving facility | On July 1, 2024

Debt Instrument [Line Items]

Letters of credit, outstanding amount

225,000,000

ABL senior secured revolving facility | On October 1, 2024

Debt Instrument [Line Items]

Letters of credit, outstanding amount

212,500,000

ABL senior secured revolving facility | On January 1, 2025

Debt Instrument [Line Items]

Letters of credit, outstanding amount

$ 200,000,000

Amended ABL senior secured revolving facility

Debt Instrument [Line Items]

Line of Credit Facility, maximum borrowing capacity

1,200,000,000

$ 1,200,000,000

Term B-7 Loans

Debt Instrument [Line Items]

Loans issued, original issue discount

$ 99.5

Secured Overnight Financing Rate (SOFR) | Senior Secured Term Loan Facilities

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

1.75%

Secured Overnight Financing Rate (SOFR) | Amended ABL senior secured revolving facility

Debt Instrument [Line Items]

Credit spread adjustment

0.10%

Secured Overnight Financing Rate Floor | Senior Secured Term Loan Facilities

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

Term Loan Facility

Debt Instrument [Line Items]

Debt instrument maturity date

Sep. 24, 2031

Long-Term Debt, face amount

$ 1,250,000,000

Amendment to Term Loan Facility

Debt Instrument [Line Items]

Debt instrument maturity date

Sep. 24, 2031

Jun. 24, 2028

Amendment to Term Loan Facility | Term B-6 Loans

Debt Instrument [Line Items]

Long-Term Debt, face amount

$ 933,000,000

Amendment to Term Loan Facility | Term B-7 Loans

Debt Instrument [Line Items]

Long-Term Debt, face amount

1,250,000,000

Amendment to Term Loan Facility | Incremental Term Loans

Debt Instrument [Line Items]

Long-Term Debt, face amount

$ 317,000,000

Amendment to Term Loan Facility | Prime Rate

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

0.75%

Amendment to Term Loan Facility | Secured Overnight Financing Rate (SOFR)

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

1.75%

Amendment to Term Loan Facility | Secured Overnight Financing Rate Floor

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

Maximum | Prime Rate | Amended ABL senior secured revolving facility

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

0.375%

Maximum | Secured Overnight Financing Rate (SOFR) | Amended ABL senior secured revolving facility

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

1.375%

Minimum | Prime Rate | Amended ABL senior secured revolving facility

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

0.125%

Minimum | Secured Overnight Financing Rate (SOFR) | Amended ABL senior secured revolving facility

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

1.125%

Derivative Instruments And He_3

Derivative Instruments And Hedging Activities - Additional Information (Detail) $ in Millions	9 Months Ended
	Nov. 02, 2024 USD ($) Derivative	Sep. 27, 2024 USD ($)	Jun. 25, 2021	Jun. 24, 2021 USD ($)
Interest Rate Cap Contracts
Derivative [Line Items]
Interest rate cap contracts, number \| Derivative	1
Amounts reported in Accumulated Other Comprehensive Income to be reclassified to interest expense, during the next twelve months	$ 14.5
Interest Rate Swap Contract \| Derivatives Designated as Hedging Instruments \| Secured Overnight Financing Rate (SOFR)
Derivative [Line Items]
Interest swap rate			2.16%
Interest Rate Swap Contract \| Cash Flow Hedging \| Derivatives Designated as Hedging Instruments
Derivative [Line Items]
Notional aggregate principal amount	$ 800	$ 500		$ 450
Interest swap rate		2.83%		2.19%
Maturity date	Sep. 24, 2031
Interest Rate Swap Contract \| Cash Flow Hedging \| Derivatives Designated as Hedging Instruments
Derivative [Line Items]
Notional aggregate principal amount		$ 300
Interest swap rate		3.37%

Outstanding Interest Rate Deriv

Outstanding Interest Rate Derivatives in Qualifying Hedging Relationships (Detail) - Cash Flow Hedging - Derivatives Designated as Hedging Instruments - Interest Rate Swap Contract $ in Millions	9 Months Ended
	Nov. 02, 2024 USD ($) Derivative	Sep. 27, 2024 USD ($)	Jun. 24, 2021 USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of Instruments \| Derivative	2
Notional aggregate principal amount \| $	$ 800	$ 500	$ 450
Interest Swap Rate		2.83%	2.19%
Maturity Date	Sep. 24, 2031
Minimum
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest Swap Rate	2.83%
Maximum
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest Swap Rate	3.37%

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities (Detail) - USD ($) $ in Thousands	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Interest Rate Swap Contracts \| Other Assets
Derivatives, Fair Value [Line Items]
Derivative Designated as Hedging Instruments Interest Rate Cap Contracts, Liability at Fair Value	$ 38,143	$ 29,075	$ 43,031

Summary of Unrealized Gains and

Summary of Unrealized Gains and Losses Deferred to Accumulated Other Comprehensive Income (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Nov. 02, 2024	Aug. 03, 2024	May 04, 2024	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Nov. 02, 2024	Oct. 28, 2023
Derivative Instruments Gain Loss [Line Items]
Income tax benefit	$ (5,800)	$ (3,300)	$ (2,800)	$ (2,800)	$ (3,100)	$ (300)
Unrealized gains, net of taxes	15,895	$ (9,037)	$ 7,735	7,618	$ 8,465	$ 947	$ 14,593	$ 17,029
Derivatives Designated as Hedging Instruments \| Interest Rate Derivatives
Derivative Instruments Gain Loss [Line Items]
Unrealized gains, before taxes	21,696			10,416			19,931	23,269
Income tax benefit	(5,801)			(2,798)			(5,338)	(6,240)
Unrealized gains, net of taxes	$ 15,895			$ 7,618			$ 14,593	$ 17,029

Reclassification of Gains and L

Reclassification of Gains and Losses from Accumulated Other Comprehensive Income into Earnings (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Nov. 02, 2024	Aug. 03, 2024	May 04, 2024	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Nov. 02, 2024	Oct. 28, 2023
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Interest benefit	$ 17,769			$ 19,680			$ 51,000	$ 58,570
Income tax expense	27,441			18,341			84,473	40,013
Net reclassification into earnings	(3,476)	$ (3,347)	$ (3,343)	(1,386)	$ (1,179)	$ (827)	(10,166)	(3,391)
Reclassification out of accumulated other comprehensive income \| Derivatives Designated as Hedging Instruments \| Accumulated net gain (loss) from cash flow hedges including portion attributable to noncontrolling interest \| Interest Rate Cap Contracts
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Interest benefit	(4,745)			(1,892)			(13,876)	(4,631)
Income tax expense	1,269			506			3,710	1,240
Net reclassification into earnings	$ (3,476)			$ (1,386)			$ (10,166)	$ (3,391)

Fair Values of Financial Assets

Fair Values of Financial Assets and Hierarchy of Level of Inputs (Detail) - USD ($) $ in Thousands	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Fair Value, Inputs, Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Cash equivalents	$ 481,491	$ 657,292	$ 269,241

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024 USD ($) Store	Oct. 28, 2023 USD ($) Store	Nov. 02, 2024 USD ($) Store	Oct. 28, 2023 USD ($) Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset impairment carrying value related to right of use assets \| $			$ 61	$ 75
Impairment charges-Long lived assets \| $	$ 3	$ 0.8	$ 11.3	3.7
Impairment of operating lease assets \| $				$ 2.6
Assets Impairments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Number of stores expected to sale			1
Impairment of store level assets, number of stores		8		11
Number of stores relocated and closed	2		2
Lease Asset Impairment
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impairment of store level assets, number of stores				3

Fair Values of Financial Liabil

Fair Values of Financial Liabilities (Detail) - USD ($) $ in Thousands		Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount	[1]	$ 1,703,224	$ 1,390,603	$ 1,393,007
Long-Term Debt, Fair Value	[1]	1,826,996	1,446,218	1,348,392
Term Loan Facility
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		1,250,000	937,379	939,783
Long-Term Debt, Fair Value		1,249,219	934,450	935,671
2025 Convertible Notes
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		156,155	156,155	156,155
Long-Term Debt, Fair Value		182,166	169,384	150,519
2027 Convertible Notes
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		297,069	297,069	297,069
Long-Term Debt, Fair Value		$ 395,611	$ 342,384	$ 262,202

[1] The table above excludes finance lease obligations, debt discount and deferred debt costs.

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023	Feb. 03, 2024
Income Tax Disclosure [Line Items]
Income tax expense	$ 27,441	$ 18,341	$ 84,473	$ 40,013
Effective tax rate	23.20%	27.40%	25.80%	26.30%
Deferred tax asset for net operating loss	$ 5,400		$ 5,400
Tax credit carryforwards	6,100		6,100
Amount of alternative minimum tax credits	100		100
Valuation allowances	7,200	$ 10,700	7,200	$ 10,700	$ 11,400
State and local jurisdiction
Income Tax Disclosure [Line Items]
Deferred tax asset for net operating loss	5,000		5,000
Tax credit carryforwards	6,000		$ 6,000
Tax credit expiration period			2025
State and local jurisdiction \| Minimum
Income Tax Disclosure [Line Items]
Net operating losses subject to expiration year			2025
State and local jurisdiction \| Maximum
Income Tax Disclosure [Line Items]
Net operating losses subject to expiration year			2041
Puerto Rico
Income Tax Disclosure [Line Items]
Deferred tax asset for net operating loss	$ 400		$ 400
Net operating losses subject to expiration year			2025
Alternative minimum tax credits, expiration life			indefinite life

Net Deferred Taxes (Detail)

Net Deferred Taxes (Detail) - USD ($) $ in Thousands	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023
Income Tax Disclosure [Abstract]
Deferred tax asset	$ 2,131	$ 2,436	$ 2,870
Deferred tax liability	254,011	227,593	237,909
Net deferred tax liability	$ 251,880	$ 225,157	$ 235,039

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($) $ in Thousands		3 Months Ended						9 Months Ended
	Aug. 15, 2023	Nov. 02, 2024	Aug. 03, 2024	May 04, 2024	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Nov. 02, 2024
Statement Equity Components [Line Items]
Shares Used for Tax Withholdings		$ 601	$ 916	$ 12,222	$ 537	$ 8,626	$ 1,962
2021 Stock Repurchase Program
Statement Equity Components [Line Items]
Stock repurchase programs, authorized amount	$ 500,000
Stock repurchase programs, authorized execution month and year	2025-08
Remaining authorized repurchase amount		324,600						$ 324,600
Common stock repurchased, shares								795,118
Common stock repurchased, value		$ 180,500						$ 180,500
Treasury Stock
Statement Equity Components [Line Items]
Shares Used for Tax Withholdings (in shares)		2,564	3,790	63,407	3,633	48,938	9,457	69,761
Shares Used for Tax Withholdings		$ 601	$ 916	$ 12,222	$ 537	$ 8,626	$ 1,962	$ 13,700
Common stock repurchased, shares		213,372	269,508	312,238	348,948	154,358	245,414

Computation of Basic and Dilute

Computation of Basic and Diluted Net Income per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Basic net income per share
Net income	$ 90,597	$ 48,551	$ 242,871	$ 112,191
Weighted average number of common shares – basic	63,563	64,707	63,723	64,852
Net income per common stock - basic	$ 1.43	$ 0.75	$ 3.81	$ 1.73
Diluted net income per share
Net income	$ 90,597	$ 48,551	$ 242,871	$ 112,191
Weighted average number of common shares – basic	63,563	64,707	63,723	64,852
Assumed exercise of stock options and vesting of restricted stock	637	95	485	172
Assumed conversion of convertible debt	419		187
Weighted average number of common shares – diluted	64,619	64,802	64,395	65,024
Net income per common stock - diluted	$ 1.4	$ 0.75	$ 3.77	$ 1.73

Net Income Per Share - Addition

Net Income Per Share - Additional Information (Detail) - shares	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive shares excluded from diluted net income per share	199,000	1,820,000	685,000	1,526,000

Stock Based Compensation - Addi

Stock Based Compensation - Additional Information (Detail)	9 Months Ended
Stock Based Compensation - Additional Information (Detail)	Nov. 02, 2024 shares
Performance Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Service-based awards, vesting period	3 years
Performance Stock Units \| Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Target award threshold range	200%
2022 Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for grant equity awards	3,967,586

Non-Cash Stock Compensation Exp

Non-Cash Stock Compensation Expense (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[1]	$ 25,410	$ 21,645	$ 69,296	$ 57,792
Restricted Stock Unit Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	11,698	11,599	32,469	32,143
Stock Option Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	5,065	5,417	14,673	14,615
Performance Stock Unit Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	$ 8,647	$ 4,629	$ 22,154	$ 11,034

[1] The amounts presented in the table above exclude taxes. For the three and nine month periods ended November 2, 2024 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 4.4 million and $ 12.3 million, respectively. For the three and nine month periods ended October 28, 2023 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 4.1 million and $ 10.9 million, respectively . Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income.

Non-Cash Stock Compensation E_2

Non-Cash Stock Compensation Expense (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Share-Based Payment Arrangement [Abstract]
Non-Cash Stock Compensation tax benefit	$ 4.4	$ 4.1	$ 12.3	$ 10.9

Stock Option Transactions (Deta

Stock Option Transactions (Detail)	9 Months Ended
Stock Option Transactions (Detail)	Nov. 02, 2024 $ / shares shares
Number of Shares
Options Outstanding at Beginning of Period \| shares	1,356,258
Options Granted \| shares	378,728
Options Exercised \| shares	(172,168)	[1]
Options Forfeited \| shares	(71,451)
Options Outstanding at End of Period \| shares	1,491,367
Weighted Average Exercise Price Per Share
Options Outstanding at Beginning of Period \| $ / shares	$ 197.9
Options Granted \| $ / shares	181.1
Options Exercised \| $ / shares	165.93	[1]
Options Forfeited \| $ / shares	208.17
Options Outstanding at End of Period \| $ / shares	$ 196.83

[1] Options exercised during the nine month period ended November 2, 2024 had a total intrinsic value of $ 12.0 million .

Stock Option Transactions (Pare

Stock Option Transactions (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Nov. 02, 2024 USD ($)
Share-Based Payment Arrangement [Abstract]
Share based compensation option exercised total intrinsic value	$ 12

Stock Options Vested and Expect

Stock Options Vested and Expected to Vest (Detail) $ / shares in Units, $ in Millions	9 Months Ended
	Nov. 02, 2024 USD ($) $ / shares shares
Share-Based Payment Arrangement [Abstract]
Vested and expected to vest, Options \| shares	1,491,367
Vested and expected to vest, Weighted Average Remaining Contractual Life (Years)	7 years 2 months 12 days
Vested and expected to vest, Weighted Average Exercise Price \| $ / shares	$ 196.83
Vested and expected to vest, Aggregate Intrinsic Value \| $	$ 80.1
Options exercisable, Options \| shares	732,110
Options exercisable, Weighted Average Remaining Contractual Life (Years)	5 years 7 months 6 days
Options exercisable, Weighted Average Exercise Price \| $ / shares	$ 202.38
Options exercisable, Aggregate Intrinsic Value \| $	$ 38.6

Weighted Average Assumptions Us

Weighted Average Assumptions Used to Estimate Fair Value of Stock Option (Detail)	9 Months Ended
	Nov. 02, 2024 $ / shares
Share-Based Payment Arrangement [Abstract]
Risk-free interest rate	4.70%
Expected volatility	42.20%
Expected life (years)	4 years
Contractual life (years)	10 years
Expected dividend yield	0%
Grant date fair value of options issued	$ 69.52

Award Grant, Vested and Forfeit

Award Grant, Vested and Forfeiture Transactions (Detail) - Non Vested Restricted Stock Unit	9 Months Ended
	Nov. 02, 2024 $ / shares shares
Number of Shares
Non-Vested Awards Outstanding at Beginning of Period \| shares	570,952
Awards Granted \| shares	315,920
Awards Vested \| shares	(164,809)	[1]
Awards Forfeited \| shares	(48,605)
Non-Vested Awards Outstanding at End of Period \| shares	673,458
Weighted Average Grant Date Fair Value Per Award
Non-Vested Awards Outstanding at Beginning of Period \| $ / shares	$ 204.97
Awards Granted \| $ / shares	184.47
Awards Vested \| $ / shares	225.24	[1]
Awards Forfeited \| $ / shares	194.98
Non-Vested Awards Outstanding at End of Period \| $ / shares	$ 191.11

[1] Restricted stock units vested during the nine month period ended November 2, 2024 had a total intrinsic value of $3 1.3 million .

Award Grant, Vested and Forfe_2

Award Grant, Vested and Forfeiture Transactions (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Nov. 02, 2024 USD ($)
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share based compensation awards vested total intrinsic value	$ 1.3

Performance Stock Units Transac

Performance Stock Units Transactions (Detail) - Performance Stock Units	9 Months Ended
	Nov. 02, 2024 $ / shares shares
Number of Shares
Non-Vested Awards Outstanding at Beginning of Period \| shares	226,917
Awards Granted \| shares	124,821
Awards Vested \| shares	(44,535)	[1]
Awards Forfeited \| shares	(11,820)
Non-Vested Awards Outstanding at End of Period \| shares	295,383
Weighted Average Grant Date Fair Value Per Award
Non-Vested Awards Outstanding at Beginning of Period \| $ / shares	$ 217.29
Awards Granted \| $ / shares	185.19
Awards Vested \| $ / shares	319.32	[1]
Awards Forfeited \| $ / shares	216.38
Non-Vested Awards Outstanding at End of Period \| $ / shares	$ 188.38

[1] Performance-based stock awards vested during the nine month period ended November 2, 2024 had a total intrinsic value of $ 10.1 million.

Performance Stock Units Trans_2

Performance Stock Units Transactions (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Nov. 02, 2024 USD ($)
Performance Shares [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation awards vested total intrinsic value	$ 10.1

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023	Jun. 26, 2023	Jun. 25, 2023
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	$ 52,500,000	$ 75,800,000	$ 76,000,000
Purchase commitments related to goods or services	1,747,700,000
ABL senior secured revolving facility
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount				$ 250,000,000	$ 150,000,000
Guarantee Performance Under Insurance And Utility Agreement
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	51,900,000	75,800,000	75,800,000
Merchandising Agreement
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	600,000	0	200,000
Letters of Credit \| ABL senior secured revolving facility \| Maximum
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	$ 160,000,000	$ 174,200,000	$ 174,000,000